Abstract
Previous studies have shown aberrant expression of ubiquitin-specific protease 14 (USP14) in multiple malignancies, suggesting an important role of USP14 in tumorigenesis. However, the functional role of USP14 in pancreatic ductal adenocarcinoma (PDAC) has never been elucidated. In this study, we found that USP14 was remarkably upregulated in PDAC tissues compared with normal pancreatic tissues. Notably, Kaplan–Meier curves showed that high expression of USP14 predicted significantly worse prognosis in PDAC patients than low expression of USP14. To determine whether USP14 could regulate the proliferation, apoptosis and metastasis of PDAC cells, we knocked down endogenous USP14 or overexpressed exogenous USP14 in Panc-1 and BxPC-3 cells. Using MTT assays, colony formation analyses, flow cytometry assays, and cell invasion and migration assays, we found that knockdown of USP14 attenuated proliferation, induced apoptosis and restrained invasion and migration of PDAC cells. Overexpression of USP14 could enhance proliferation, prevent apoptosis and promote invasion and migration of PDAC cells. In addition, USP14 could regulate the expression of cyclin D1, PCNA and E-cadherin, three important carcinogenic factors, in PDAC cells. These findings suggest that USP14 might play an important role in promoting the tumorigenesis of PDAC and thus be a promising therapeutic target to prevent PDAC progression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ansari D et al (2016) Pancreatic cancer: yesterday, today and tomorrow. Future Oncol 12:1929–1946. https://doi.org/10.2217/fon-2016-0010
Bayraktar S et al (2013) USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer. Cancer J 19:10–17. https://doi.org/10.1097/ppo.0b013e3182801b3a
D’Arcy P, Wang X, Linder S (2015) Deubiquitinase inhibition as a cancer therapeutic strategy. Pharmacol Ther 147:32–54. https://doi.org/10.1016/j.pharmthera.2014.11.002
Fu Y, Ma G, Liu G, Li B, Li H, Hao X, Liu L (2018) USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer. Cancer Med 7:5577–5588. https://doi.org/10.1002/cam4.1770
Hu M et al (2005) Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J 24:3747–3756. https://doi.org/10.1038/sj.emboj.7600832
Huang G, Li L, Zhou W (2015) USP14 activation promotes tumor progression in hepatocellular carcinoma. Oncol Rep 34:2917–2924. https://doi.org/10.3892/or.2015.4296
Kaistha BP et al (2017) The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators. Oncotarget 8:66215–66225. https://doi.org/10.18632/oncotarget.19882
King J, Bouvet M, Singh G, Williams J (2017) Improving theranostics in pancreatic cancer. J Surg Oncol 116:104–113. https://doi.org/10.1002/jso.24625
Lamb J et al (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323–334. https://doi.org/10.1016/s0092-8674(03)00570-1
Lee BH et al (2010) Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467:179–184. https://doi.org/10.1038/nature09299
Lee BH et al (2016) USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites. Nature 532:398–401. https://doi.org/10.1038/nature17433
Liao Y et al (2017) Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor. Cell Death Dis 8:e2585. https://doi.org/10.1038/cddis.2016.477
Mialki RK, Zhao J, Wei J, Mallampalli DF, Zhao Y (2013) Overexpression of USP14 protease reduces I-kappaB protein levels and increases cytokine release in lung epithelial cells. J Biol Chem 288:15437–15441. https://doi.org/10.1074/jbc.c112.446682
Michl P, Gress TM (2013) Current concepts and novel targets in advanced pancreatic cancer. Gut 62:317–326. https://doi.org/10.1136/gutjnl-2012-303588
Moldovan GL, Pfander B, Jentsch S (2007) PCNA, the maestro of the replication fork. Cell 129:665–679. https://doi.org/10.1016/j.cell.2007.05.003
Peth A, Kukushkin N, Bosse M, Goldberg AL (2013) Ubiquitinated proteins activate the proteasomal ATPases by binding to Usp14 or Uch37 homologs. J Biol Chem 288:7781–7790. https://doi.org/10.1074/jbc.m112.441907
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30. https://doi.org/10.3322/caac.21442
Swatek KN, Komander D (2016) Ubiquitin modifications. Cell Res 26:399–422. https://doi.org/10.1038/cr.2016.39
Tian Z et al (2014) A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. Blood 123:706–716. https://doi.org/10.1182/blood-2013-05-500033
van Roy F, Berx G (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65:3756–3788. https://doi.org/10.1007/s00018-008-8281-1
Veisani Y, Jenabi E, Khazaei S, Nematollahi S (2018) Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach. Public Health 156:87–91. https://doi.org/10.1016/j.puhe.2017.12.015
Wang Y et al (2015) Ubiquitin-specific protease 14 (USP14) regulates cellular proliferation and apoptosis in epithelial ovarian cancer. Med Oncol 32:379. https://doi.org/10.1007/s12032-014-0379-8
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (2013) Recent progress in pancreatic cancer. CA Cancer J Clin 63:318–348. https://doi.org/10.3322/caac.21190
Wu N, Liu C, Bai C, Han YP, Cho WC, Li Q (2013) Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of beta-catenin. Int J Mol Sci 14:10749–10760. https://doi.org/10.3390/ijms140610749
Xia X et al (2019) Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide. J Exp Clin Cancer Res: CR 38:220. https://doi.org/10.1186/s13046-019-1227-7
Yu F et al (2018) Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14. Cancer Lett 427:74–84. https://doi.org/10.1016/j.canlet.2018.04.022
Zhang B, Li M, Huang P, Guan XY, Zhu YH (2017a) Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma. Thoracic Cancer 8:344–349. https://doi.org/10.1111/1759-7714.12453
Zhang J, Zhang D, Sun L (2017b) Knockdown of ubiquitin-specific protease 14 (USP14) inhibits the proliferation and tumorigenesis in esophageal squamous cell carcinoma cells. Oncol Res 25:249–257. https://doi.org/10.3727/096504016x693164
Zhu L et al (2016) Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis. J Mol Histol 47:69–80. https://doi.org/10.1007/s10735-015-9650-3
Zhu Y, Zhang Y, Sui Z, Zhang Y, Liu M, Tang H (2017) USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells. Oncotarget 8:48725–48736. https://doi.org/10.18632/oncotarget.10706
Acknowledgements
This work was supported by the Taicang Science and Technology Program (No. TC2017YYJC04).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We declare that we have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hang, C., Gong, C., Fang, Y. et al. Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma. J Mol Histol 52, 187–196 (2021). https://doi.org/10.1007/s10735-020-09934-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-020-09934-0